BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Ren F, Chai Y, Xue Z, Shen C, Zhang X, Lv Y, Hu L. Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection. Oncol Lett 2019;17:165-74. [PMID: 30655752 DOI: 10.3892/ol.2018.9618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ma B, Meng H, Shen A, Ma Y, Zhao D, Liu G, Zheng S, Tian Y, Zhang W, Li Q, Li S. Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection. Gastroenterol Res Pract 2021;2021:6616062. [PMID: 33833794 DOI: 10.1155/2021/6616062] [Reference Citation Analysis]
2 Ohira M, Yoshizumi T, Yugawa K, Kosai-Fujimoto Y, Inokuchi S, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Taketomi A, Mori M. Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma. Surg Today 2020;50:379-88. [PMID: 31667580 DOI: 10.1007/s00595-019-01905-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Miyazaki K, Morine Y, Imura S, Ikemoto T, Saito Y, Yamada S, Tokuda K, Okikawa S, Yamashita S, Oya T, Tsuneyama K, Shimada M. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8+ tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocarcinoma. Surg Today 2021. [PMID: 34009433 DOI: 10.1007/s00595-021-02295-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Beetz O, Weigle CA, Cammann S, Vondran FWR, Timrott K, Kulik U, Bektas H, Klempnauer J, Kleine M, Oldhafer F. Preoperative leukocytosis and the resection severity index are independent risk factors for survival in patients with intrahepatic cholangiocarcinoma. Langenbecks Arch Surg 2020;405:977-88. [PMID: 32815017 DOI: 10.1007/s00423-020-01962-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Yugawa K, Itoh S, Yoshizumi T, Morinaga A, Iseda N, Toshima T, Harada N, Kohashi K, Oda Y, Mori M. Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma. Int J Clin Oncol 2021. [PMID: 34117554 DOI: 10.1007/s10147-021-01962-4] [Reference Citation Analysis]
6 He C, Zhao C, Lu J, Huang X, Chen C, Lin X. Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study. Front Oncol 2021;11:672607. [PMID: 34221991 DOI: 10.3389/fonc.2021.672607] [Reference Citation Analysis]
7 Noguchi D, Kuriyama N, Nakagawa Y, Maeda K, Shinkai T, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Kishiwada M, Sakurai H, Mizuno S. The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers. PLoS One 2021;16:e0245946. [PMID: 33507925 DOI: 10.1371/journal.pone.0245946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Yu H, Wang M, Wang Y, Yang J, Deng L, Bao W, He B, Lin Z, Chen Z, Chen K, Zhang B, Liu F, Yu Z, Ye L, Jin B, Chen G. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study. Cancer Med 2021;10:4768-80. [PMID: 34105304 DOI: 10.1002/cam4.4035] [Cited by in F6Publishing: 2] [Reference Citation Analysis]